Learn more at LeadIQ.com

Insights

Epigenetic Therapies DURECT Corporation is developing epigenetic therapies targeting dysregulated DNA methylation for serious conditions like acute organ injury and cancer, presenting opportunities to collaborate with healthcare providers for clinical trials and treatment advancements.

FDA Fast Track Designation Larsucosterol, DURECT's lead drug candidate for alcohol-associated hepatitis (AH) treatment, has received FDA Fast Track Designation, indicating potential accelerated approval, creating a window for sales discussions with hospitals and pharmacies.

Non-Opioid Analgesic POSIMIR®, DURECT's FDA-approved non-opioid analgesic using innovative SABER® platform technology, offers a novel pain management solution, presenting sales opportunities to target pain clinics, surgical centers, and healthcare institutions.

Strategic Partnerships DURECT's recent partnership with Charles River Laboratories for ALZET Osmotic Pumps expansion signals growth in research and development collaborations, providing openings for sales engagements with research institutions and pharmaceutical companies.

Strong Financials With revenue ranging from $10M to $50M and recent funding of $15M, DURECT demonstrates financial stability, making it an attractive prospect for potential investors and business partners seeking to leverage its innovative pharmaceutical solutions.

Similar companies to DURECT Corporation

DURECT Corporation Tech Stack

DURECT Corporation uses 8 technology products and services including Google Analytics, Drupal, Font Awesome, and more. Explore DURECT Corporation's tech stack below.

Google Analytics
Analytics
Drupal
Content Management System
Font Awesome
Font Scripts
Typekit
Font Scripts
Google Font API
Font Scripts
jQuery
Javascript Libraries
Underscore.js
Javascript Libraries
Google Tag Manager
Tag Management

Media & News

DURECT Corporation's Email Address Formats

DURECT Corporation uses at least 1 format(s):

DURECT Corporation Email Formats	Example	Percentage
First.Last@durect.com	John.Doe@durect.com	82%
FLast@durect.com	JDoe@durect.com	15%
Last.First@durect.com	Doe.John@durect.com	2%
Last@durect.com	Doe@durect.com	1%

Frequently Asked Questions

What is DURECT Corporation's phone number?

You can contact DURECT Corporation's main corporate office by phone at

+1-408-777-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is DURECT Corporation's official website and social media links?

DURECT Corporation's official website is durect.com and has social profiles on LinkedIn.

How much revenue does DURECT Corporation generate?

As of June 2024, DURECT Corporation's annual revenue reached $35M.

What is DURECT Corporation's NAICS code?

DURECT Corporation's NAICS code is 332994 - Small Arms, Ordnance, and Ordnance Accessories Manufacturing.

How many employees does DURECT Corporation have currently?

As of June 2024, DURECT Corporation has approximately 107 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Chief Medical Officer: N. S.Chief Financial Officer: T. P.Chief Patent Counsel: S. H.. Explore DURECT Corporation's employee directory with LeadIQ.

What industry does DURECT Corporation belong to?

DURECT Corporation operates in the Pharmaceutical Manufacturing industry.

What technology does DURECT Corporation use?

DURECT Corporation's tech stack includes Google AnalyticsDrupalFont AwesomeTypekitGoogle Font APIjQueryUnderscore.jsGoogle Tag Manager.

What is DURECT Corporation's email format?

DURECT Corporation's email format typically follows the pattern of . Find more DURECT Corporation email formats with LeadIQ.

How much funding has DURECT Corporation raised to date?

As of June 2024, DURECT Corporation has raised $15M in funding. The last funding round occurred on Jul 20, 2023 for $15M.

When was DURECT Corporation founded?

DURECT Corporation was founded in 1998.

DURECT Corporation

DURECT Corporation

Pharmaceutical Manufacturing51-200 Employees

DURECT is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer. Larsucosterol, DURECT’s lead drug candidate, binds to and inhibits the activity of DNA methyltransferases (DNMTs), epigenetic enzymes that are elevated and associated with hypermethylation found in alcohol-associated hepatitis (AH) patients. Larsucosterol is in clinical development for the potential treatment of AH, for which FDA has granted a Fast Track Designation; non-alcoholic steatohepatitis (NASH) is also being explored. In addition, POSIMIR® (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the innovative SABER® platform technology, is FDA-approved and is exclusively licensed to Innocoll Pharmaceuticals for sale and distribution in the United States.

Company Overview

Phone number: ✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-408-777-****
Website: durect.com
NAICS Code: 332994 - Small Arms, Ordnance, and Ordnance Accessories Manufacturing
Founded: 1998
Employees: 51-200

Media & News

Funding & Financials

$15M
DURECT Corporation has raised a total of $15M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2023 in the amount of $15M.
$10M$50M
DURECT Corporation's revenue is in the range of $10M$50M

Funding & Financials

$15M
DURECT Corporation has raised a total of $15M of funding over 3 rounds. Their latest funding round was raised on Jul 20, 2023 in the amount of $15M.
$10M$50M
DURECT Corporation's revenue is in the range of $10M$50M

Company Leadership

N. S.
Chief Medical Officer
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
T. P.
Chief Financial Officer
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. H.
Chief Patent Counsel
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. B.
Pres/Ceo
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. L.
Senior Vice President, Business Development, Commercial, Medical Affairs
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

B. T.
Senior Executive Administrator And Manager Administrative Svcs
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. E.
Vp Regulatory Affairs
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. G.
Vp, Birmingham Operations
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. J.
Senior Vice President, Operations And Corporate Quality Assurance
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. M.
Svp Operations
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for DURECT Corporation and Millions of Other Companies
Sign up for full access to DURECT Corporation information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.